Glycivas M 60mg/500mg Tablet PR

Name: Glycivas M 60mg/500mg Tablet PR
Brand: Cresha Lifesciences
Price: 71 INR

Prescription Required

Marketer

Cresha Lifesciences

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Glycivas M 60mg/500mg Tablet PR

DiabetaComb 60mg/500mg tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. DiabetaComb 60mg/500mg tablets should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly influences diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Always carry a fast-acting sugar source to counteract hypoglycemia. Alcohol consumption should be minimized due to increased hypoglycemia risk. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease to your physician prior to commencing treatment. Pregnant or lactating women should consult their doctor before use. Regular blood glucose monitoring is essential, and your physician may recommend blood tests to track blood cell counts and liver function.

Primary Ingredients of Glycivas M 60mg/500mg Tablet PR

No text provided. Please provide the text you wish to be rephrased.

Uses of Glycivas M 60mg/500mg Tablet PR

Adult-onset diabetes

Major Benefits of Glycivas M 60mg/500mg Tablet PR:

Follow your physician's instructions or consult the product label for dosage guidance. Administer Glycivas M 60mg/500mg Tablet PR with meals.

Common Side effects of Glycivas M 60mg/500mg Tablet PR:

Hypoglycemia (low blood glucose level)
Headache
Dizziness
Diarrhea
Upper respiratory tract infection
Nausea
Flatulence
Constipation

How to use Glycivas M 60mg/500mg Tablet PR:

Follow your physician's instructions or consult the product label for proper administration. Glycivas M 60mg/500mg Tablet PR should be ingested with a meal.

How Glycivas M 60mg/500mg Tablet PR works:

Glycivas M tablets (60mg/500mg) are a dual-action antidiabetic medication containing gliclazide and metformin.

SAFETY ADVICE

AlcoholUNSAFE

Concurrent alcohol use with Glycivas M 60mg/500mg tablets is inadvisable.

PregnancyCONSULT YOUR DOCTOR

Using Glycivas M 60mg/500mg tablets during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in exceptional, life-threatening circumstances where the potential benefits clearly outweigh the known dangers. Always seek medical advice before taking this medication.

Breast feedingCONSULT YOUR DOCTOR

Maternal use of Glycivas M 60mg/500mg tablets during lactation is potentially hazardous. Available evidence indicates possible transfer to breast milk, posing a risk to the infant.

DrivingCAUTION

Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.

KidneyCAUTION

Patients with kidney impairment should exercise caution when using Glycivas M 60mg/500mg Tablet PR, potentially requiring dosage modification. Consult your physician for guidance. Glycivas M 60mg/500mg Tablet PR is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverCAUTION

Patients with liver impairment should use Glycivas M 60mg/500mg Tablet PR cautiously, as dose modification may be necessary. Individuals with mild to moderate liver disease should begin with a low Glycivas M 60mg/500mg Tablet PR dosage. Glycivas M 60mg/500mg Tablet PR is contraindicated in patients with severe liver disease. Medical advice is recommended.

What if you forget to take Glycivas M 60mg/500mg Tablet PR :

Should you forget a Glycivas M 60mg/500mg Tablet PR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Glycivas M 60mg/500mg Tablet PR

Label	Value
Developing Habits	No.
Type of Treatment	Diabetes Management

FAQs on Glycivas M 60mg/500mg Tablet PR

Glycivas M 60mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This treatment improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glycivas M is not suitable for type 1 diabetes.

Glycivas M 60mg/500mg Tablet PR commonly causes side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, may also occur. Prolonged use can result in vitamin B12 deficiency.

Glycivas M 60mg/500mg Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.

Glycivas M 60mg/500mg Tablet PR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Glycivas M 60mg/500mg Tablet PR and seek immediate medical attention.

Prolonged Glycivas M 60mg/500mg Tablet PR use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.

Glycivas M 60mg/500mg Tablet PR is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).

Consuming alcohol with Glycivas M 60mg/500mg tablets is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.

Glycivas M 60mg/500mg Tablets are a dual-action diabetes medication combining gliclazide and metformin. This treatment improves blood sugar control in adults with type 2 diabetes mellitus, when used alongside a healthy diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.

Glycivas M 60mg/500mg Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.

Glycivas M 60mg/500mg Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.

Glycivas M 60mg/500mg Tablet PR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is best avoided in individuals with kidney disease, the elderly, or those consuming large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glycivas M 60mg/500mg Tablet PR and seek immediate medical attention.

Prolonged Glycivas M 60mg/500mg Tablet PR use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. Preventive measures suggested by some researchers include annual supplemental vitamin B12 intake.

Combining Glycivas M 60mg/500mg tablets with alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.

MRP 87

18% off

Inclusive of all taxes

Quantity:

of Tablet pr

Glycivas M 60mg/500mg Tab...

MRP 87

18% off

Hi there!

Connect

Social Links

Drugs